Report copyright - HIGHLIGHTS OF PRESCRIBING INFORMATION …...drugs that may prolong the PR interval. (5.1, 7.3, 12.2, 17) Severe Skin Reactions: Discontinue if severe rash develops. (5.2, 17) Hyperbilirubinemia:
Please pass captcha verification before submit form